FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

780402006: Product containing only rotigotine in transdermal dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3742579015 Product containing only rotigotine in transdermal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3742580017 Rotigotine only product in transdermal dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


5 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only rotigotine in transdermal dose form (medicinal product form) est un(e) (attribut) Product containing only rotigotine (medicinal product) true Inferred relationship Some
Product containing only rotigotine in transdermal dose form (medicinal product form) est un(e) (attribut) Rotigotine-containing product in transdermal dose form true Inferred relationship Some
Product containing only rotigotine in transdermal dose form (medicinal product form) Count of base of active ingredient un false Inferred relationship Some
Product containing only rotigotine in transdermal dose form (medicinal product form) a une forme pharmaceutique (attribut) forme transdermique (forme pharmaceutique) true Inferred relationship Some
Product containing only rotigotine in transdermal dose form (medicinal product form) a pour principe actif (attribut) Rotigotine (substance) true Inferred relationship Some 1
Product containing only rotigotine in transdermal dose form (medicinal product form) Plays role Antiparkinson therapeutic role true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch est un(e) (attribut) True Product containing only rotigotine in transdermal dose form (medicinal product form) Inferred relationship Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch est un(e) (attribut) True Product containing only rotigotine in transdermal dose form (medicinal product form) Inferred relationship Some
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) est un(e) (attribut) True Product containing only rotigotine in transdermal dose form (medicinal product form) Inferred relationship Some
Rotigotine 125 microgram/hour prolonged-release transdermal patch est un(e) (attribut) True Product containing only rotigotine in transdermal dose form (medicinal product form) Inferred relationship Some
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch est un(e) (attribut) True Product containing only rotigotine in transdermal dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start